Hepatic delivery of particulates in the submicron range by a hydrodynamics‐based procedure: implications for particulate gene delivery systems
- 16 February 2004
- journal article
- research article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (4), 455-463
- https://doi.org/10.1002/jgm.531
Abstract
Background A large‐volume intravenous (i.v.) injection of DNA, i.e. a hydrodynamics‐based transfection procedure, is known to be an efficient and liver‐specific method of in vivo gene delivery. However, little is available on an applicable particle size in the procedure. Methods We examined the effect of particle size on the hepatic delivery by the hydrodynamics‐based procedure, using fluorescein isothiocyanate labeled polystyrene microspheres (MS) of 50, 200 or 500 nm in diameter. MS were injected intravenously to mice by a conventional (normal) or the hydrodynamics‐based procedure and their degree of hepatic uptake was determined fluorometrically. Results For all sizes tested, the two procedures were similar in terms of the apparent degree of hepatic uptake, whereas the intrahepatic localization of MS was apparently different between the procedures as shown by an examination of frozen tissue sections. In mice with gadolinium chloride induced Kupffer cell blockade, the hepatic uptake of MS following the normal procedure was decreased while that of the hydrodynamics‐based procedure was less affected. This phenomenon of enhanced hepatic delivery seemed to be more effective for larger particles. Confocal microscopic observation of hepatocyte suspensions indicated that part of the injected MS‐50 was delivered intracellularly following the hydrodynamics‐based procedure, whereas almost all the observed MS‐200 and MS‐500 were detected in the extracellular compartment or on the surface of the cells. This was supported by the fact that most of the injected MS existed pericellularly around the transgene‐expressing cells. Conclusions The hydrodynamics‐based procedure facilitated extravasation and hepatic delivery of MS. Larger MS were more efficiently extravasated and trapped by the liver, whereas intracellular delivery hardly occurred with them. Copyright © 2004 John Wiley & Sons, Ltd.Keywords
This publication has 30 references indexed in Scilit:
- Gene Therapy Progress and Prospects: Nonviral vectorsGene Therapy, 2002
- Cellular Gene Dose and Kinetics of Gene Expression in Mouse Livers Transfected by High-Volume Tail-Vein Injection of Naked DNADNA and Cell Biology, 2002
- Uptake by mouse liver and intracellular fate of plasmid DNA after a rapid tail vein injection of a small or a large volumeThe Journal of Gene Medicine, 2002
- Enhanced gene expression in mouse muscle by sustained release of plasmid DNA using PPE-EA as a carrierGene Therapy, 2002
- CpG-Depleted Plasmid DNA Vectors with Enhanced Safety and Long-Term Gene Expression in VivoMolecular Therapy, 2002
- High‐level expression of naked DNA delivered to rat liver via tail vein injectionThe Journal of Gene Medicine, 2002
- Combined IL-12 and GM-CSF gene therapy for murine hepatocellular carcinomaCancer Gene Therapy, 2001
- Regression of Human Mammary Adenocarcinoma by Systemic Administration of a Recombinant Gene Encoding the hFlex-TRAIL Fusion ProteinMolecular Therapy, 2001
- Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery systemGene Therapy, 2000
- The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)FEBS Letters, 1984